Reports

93 Results (Page 1 of 4)

Indonesia Markets Research Reports

OTC & Nutraceuticals

Indonesia Over The Counter (OTC) Pharmaceuticals Market Analysis

Indonesia's over-the-counter (OTC) pharmaceuticals market size was valued at $825 Mn in 2022 and is estimated to expand at a CAGR of 5.54% from 2022 to 2030 and will reach $1270 Mn in 2030. OTC are non-prescription medications and are a vital component of the healthcare system, offering consumers accessible solutions for a wide range of common health issues. The market is segmented by product type and distribution channel. The key market players are Johnson and Johnson Services Inc (USA), Bayer AG (Germany), Novartis AG (Switzerland) and others.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Nov, 2023 | PRICE: $3999

Pharmaceuticals

Indonesia Cancer Immunotherapy Market Analysis

Indonesia's cancer immunotherapy market is expected to grow from $675 Mn in 2022 to $1,169 Mn in 2030 with a CAGR of 7.1% for the forecasted year 2022-30. The rising prevalence of cancer and supportive government policies to promote immunotherapy options in Indonesia is responsible for the expansion of the market. The Indonesia cancer immunotherapy market is segmented by type, application, and end user. Asa Rén, Cordlife, and Bristol-Myers Squibb are the major players in the Indonesia cancer immunotherapy market.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Oct, 2023 | PRICE: $3999

Pharmaceuticals

Indonesia Radiotherapy Market Analysis

By 2030, it is anticipated that the Indonesia Radiotherapy Market will reach a value of $xx Mn from $41 Mn in 2022, growing at a CAGR of xx% during 2022-30. The Radiotherapy Therapeutics Market in Indonesia is dominated by a few domestic players such as Viet Medical Equipment, Shimadzu Indonesia, and Varian Medical Systems. The radiotherapy market in Indonesia is segmented into different types, technology, procedures, application, and end-user. The major risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives and reimbursement policy. The demand for Indonesia Radiotherapy is increasing on account of the rise in cancer cases in the country.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Jul, 2023 | PRICE: $3999

Healthcare Services

Indonesia Home Healthcare Market Analysis

Indonesia's home healthcare market was valued at $2.18 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 7.93% from 2022-30 and will reach $4 Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, The increased prevalence of chronic ailments. The market is segmented by equipment outlook and by services. Some key players in this market are Noble Care, Allium Healthcare, Econ Home Care, Elderly Care, and PT. Medikabina Sejahtera home healthcare.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Jul, 2023 | PRICE: $3999

Pharmaceuticals

Indonesia Cardiovascular Drugs Market Analysis

This report presents a strategic analysis of the Indonesia Cardiovascular Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Indonesia Cardiovascular Drugs Market, offering unmatched value, accuracy and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Jul, 2023 | PRICE: $3999

Clinical Trials

Indonesia Oncology Clinical Trials Market Analysis

Indonesia's oncology clinical trials market is projected to grow from $75.9 Mn in 2022 to $116.5 Mn by 2030, registering a CAGR of 5.5% during the forecast period of 2022-30. The market will be driven by the increasing need for innovative and effective therapies with the rising incidence of cancers and increased investments in healthcare infrastructure. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Novartis International AG & Kalbe Farma.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Jun, 2023 | PRICE: $3999

Digital Health

Indonesia Artificial Intelligence (AI) in Healthcare Market Analysis

Indonesia's Artificial Intelligence (AI) In Healthcare Market is projected to grow from $0.04 Bn in 2022 to $0.82 Bn by 2030, registering a CAGR of 45.22% during the forecast period of 2022-30. The market will be driven by more investments in AI technology by healthcare providers and a rise in professionals with expertise in the technology. The market is segmented by healthcare components & by healthcare applications. Some of the major players include IBM Watson Health, Philips Healthcare, Alodokter & Asa Ren Pte Ltd.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Jun, 2023 | PRICE: $3999

Pharmaceuticals

Indonesia Pharmaceutical Market Analysis

This report presents a strategic analysis of the Indonesia Pharmaceutical Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Indonesia Pharmaceutical Market, offering unmatched value, accuracy and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Jun, 2023 | PRICE: $3999

Pharmaceuticals

Indonesia Diabetes Therapeutics Market Analysis

Indonesia's diabetes therapeutics market is expected to grow from $863 Mn in 2022 to $1,811 Mn in 2030 with a CAGR of 9.7% for the forecasted year 2022-2030. The increasing awareness regarding the consequences of diabetes in Indonesia as well as supportive government policies to promote diabetes awareness in Indonesia are the major market drivers. The Indonesia diabetes therapeutics market is segmented by type, application, drug, route of administration, and distribution channel. Tatarasa, Dexa Group, and GlaxoSmithKline are the major players in the Indonesia diabetes therapeutics market.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Jun, 2023 | PRICE: $3999

Pharmaceuticals

Indonesia Anti Aging Therapeutics Market Analysis

Indonesia's anti-ageing therapeutics market is projected to grow from $4 Mn in 2022 to $12 Mn in 2030 with a CAGR of 16.53% for 2022-2030. The market expansion is attributed to the growing elderly population and supportive government policies in Indonesia. The Indonesia anti-ageing therapeutics market is segmented by product, treatment, target group, type of ageing, type of molecules, mechanism of action, ingredient, and distribution channel. Some of the key players in the market include Asa Rén, PT Mitra Asiatek Biosensor, and Procter & Gamble.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Jun, 2023 | PRICE: $3999

Pharmaceuticals

Indonesia Oncology Drugs Market Analysis

By 2030, it is anticipated that the Indonesia oncology drugs market will reach a value of $xx Bn from $1.18 Bn in 2022, growing at a CAGR of xx% during 2022-2030. The oncology drug market in Indonesia is dominated by a few large pharmaceutical companies such as Bio Farma, Innogene by Kalbe Farma and Takeda Pharma. The oncology market in Indonesia is segmented into different therapeutic areas and different treatment types. The major factors affecting the Indonesian oncology drugs market are the increasing disease burden of non-communicable diseases like cancer and the lack of healthcare facilities for cancer treatment in most areas of Indonesia.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Jun, 2023 | PRICE: $3999

Pharmaceuticals

Indonesia Vaccines Market Analysis

This report presents a strategic analysis of the Indonesia Vaccines Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Indonesia Vaccines Market, offering unmatched value, accuracy and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Jun, 2023 | PRICE: $3999

Medical Devices

Indonesia Diabetes Devices Market Analysis

Indonesia's Diabetes Devices Market is expected to witness growth from $136 Mn in 2022 to $238 Mn in 2030 with a CAGR of 7.20% for the forecasted year 2022-2030. With roughly 10 million sufferers, diabetes is a condition that is very common in Indonesia. This indicates a sizable market for diabetes devices. The market is segmented by type and by the end user. Some key players in this market include PT. Ravindra Putrapratama, Tawada Healthcare, Johnson & Johnson, Medtronic, Roche, Ascensia Diabetes Care and Dexcom.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Jun, 2023 | PRICE: $3999

Digital Health

Indonesia Telemedicine Market Analysis

This report presents a strategic analysis of the Indonesia Telemedicine Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Indonesia Telemedicine Market, offering unmatched value, accuracy and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Jun, 2023 | PRICE: $3999

Healthcare Services

Indonesia In Vitro Fertilisation (IVF) Service Market Analysis

This report presents a strategic analysis of Indonesia's In Vitro Fertilisation (IVF) Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about Indonesia In Vitro Fertilisation (IVF) Service Market, offering unmatched value, accuracy and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Jun, 2023 | PRICE: $3999

OTC & Nutraceuticals

Indonesia Nutritional Supplements Market Analysis

By 2030, it is anticipated that the Indonesia Nutrition and Supplements market will reach a value of $xx Bn from $2.29 Bn in 2022, growing at a CAGR of xx% during 2022-2030. The market is primarily dominated by local players such as Nature’s Sunshine Products, Darya-Varia Laboratoria Tbk, and Citra Nusa Insan Cemerlang. The market for nutrition and supplements in Indonesia is primarily driven by government initiatives, increasing consumer awareness for health and lifestyle, and international supplements business. The Indonesia nutrition and supplements market in Indonesia is segmented by Type, Product, application, and Distribution Channel.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Jun, 2023 | PRICE: $3999

Medical Devices

Indonesia Cardiac Surgery Instruments Market Analysis

Indonesia's Cardiac Surgery Instruments Market is expected to witness growth from $12 Mn in 2022 to $21 Mn in 2030 with a CAGR of 6.60% for the forecasted year 2022-2030. Heart disease is the leading cause of death in Indonesia, accounting for 28.56% of all fatalities, which is driving up demand for cardiac surgery equipment in the Indonesian healthcare market. The market is segmented by type, application and by the end user. Some key players in this market include PT. Oneject Indonesia, PT. Provital Perdana, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Jun, 2023 | PRICE: $3999

Digital Health

Indonesia Artificial Intelligence (AI) in Diagnostics Market Analysis

Indonesia's Artificial Intelligence (AI) in the diagnostics market is projected to grow from $6.0 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022-2030. The market will be driven by rising privatization in Indonesia and increasing adoption of AI technology in the country. The market is segmented by component & by diagnosis. Some of the major players include IBM Watson Health, Siemens Healthineers & Philips Healthcare.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Jun, 2023 | PRICE: $3999

Healthcare Services

Indonesia Dental Care Market Analysis

Indonesia's Dental Care Services Market size is at around $215.28Mn in 2022 and is projected to reach $353.62Mn in 2030, exhibiting a CAGR of 6.4% during the forecast period 2022 to 2030. The largest market of dental care in Asia, driven by aesthetic sensitive needs and a growing ageing population Japan is dominated by huge corporations J. Morita Corporation, Mitsui & Co. and GC Corporation. This report is segmented by treatment type, age group, and by clinical setup and by demography and provides in-depth insights into opportunities for expansion.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: May, 2023 | PRICE: $3999

Medical Devices

Indonesia ENT Devices Market Analysis

The Indonesia ENT Devices Market is projected to grow from $140 Mn in 2022 to $220 Mn by 2030, registering a CAGR of 6% during the forecast period of 2022 - 2030. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the Indonesia ENT devices market include Innonovatech Medica, Dharma Intisemesta, and Bina Medika Lestari.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: May, 2023 | PRICE: $3999

Medical Devices

Indonesia Coronary Stents Market Analysis

The Indonesia Coronary Stents Market is expected to witness growth from $68 Mn in 2022 to $98 Mn in 2030 with a CAGR of 4.75% for the forecasted year 2022-2030. The older population in Indonesia is expanding and is more likely to acquire coronary heart disease. The need for coronary stents is anticipated to rise as the senior population continues to rise. The market is segmented by type, by mode of delivery, by materials and by end user. Some key players in this market include PT. Graha Farma, PT. Mensa Bina Sukses, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific and Philips Healthcare.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: May, 2023 | PRICE: $3999

Medical Devices

Indonesia Contraceptive Devices Market Analysis

The Indonesia Contraceptive Devices Market is expected to witness growth from $77 Mn in 2022 to $143 Mn in 2030 with a CAGR of 8.00% for the forecasted year 2022-2030. By 2050, the population of Indonesia is going to increase to 305 million from its current size. The need for contraceptive devices is anticipated to rise along with the population. The market is segmented by type and by gender. Some key players in this market include DKT Indonesia, Kimia Farma, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer and Teva Pharmaceutical.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: May, 2023 | PRICE: $3999

Digital Health

Indonesia 3D Imaging Market Analysis

Indonesia's 3D imaging market is projected to grow from $xx Bn in 2022 to $xx Bn by 2030, registering a CAGR xx% during the forecast period of 2022-30. The market will be driven by the government's increasing focus on the healthcare sector and the rising number of private hospitals and clinics. The market is segmented by product, by application, end-user & by portability. Some of the major players include GE Healthcare, Siemens Healthineers & Philips Healthcare.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: May, 2023 | PRICE: $3999

Medical Devices

Indonesia ECG Equipments Market Analysis

The Indonesia ECG Equipment Market is expected to witness growth from $53 Mn in 2022 to $94 Mn in 2030 with a CAGR of 7.30% for the forecasted year 2022-2030. Indonesia is seeing an increase in the number of cardiac illnesses, which is driving up demand for ECG equipment for monitoring and diagnostics. The market is segmented by product type and by the end user. Some key players in this market include Graha Ismaya, PT Urogen Advanced Solutions, PT Transmedic, Johnson & Johnson, Philipps Healthcare, Medtronic, GE Healthcare, and Nihon Kohden.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Apr, 2023 | PRICE: $3999

Pharmaceuticals

Indonesia Cardiovascular Diseases Therapeutics Market Analysis

The Indonesia cardiovascular disease therapeutics is projected to grow from $976 Mn in 2022 to $1,706 Mn in 2030 with a CAGR of 7.22% for the year 2022-2030. Rapid urbanization leading to shifting lifestyle behaviours in the population of Indonesia resulting in the increased incidence of cardiovascular diseases is responsible for the growth of the market. The Indonesia cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by the end user. Combiphar, Ivosights, and Bayer are the major players in the Indonesia cardiovascular disease therapeutics market.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Apr, 2023 | PRICE: $3999

subscribe to our newsletter
up